Domů › Malobuněčný karcinom plic › Kalifornie › Los Angeles
Klinické studie Malobuněčný karcinom plic v Los Angeles, CA
20 studií pro Malobuněčný karcinom plic hledá účastníky v lokalitách v Los Angeles a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1
- University of California - Los Angeles, Los Angeles
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
Probíhá náborFáze 3
- GSK Investigational Site, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Probíhá náborFáze 1/2
- University of Southern California, Los Angeles
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Probíhá náborFáze 1/2
- START Los Angeles, Los Angeles
A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
Probíhá náborFáze 2
- Valkyrie Clinical Trials, Inc., Los Angeles
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Probíhá náborFáze 3
- Valkyrie Clinical Trials, Los Angeles
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Probíhá náborFáze 1/2
- Avenzo Therapeutics Recruiting Site, Los Angeles
- Avenzo Therapeutics Recruiting Site, Los Angeles
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of California LA, Los Angeles
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Probíhá náborFáze 1/2
- Cedars Sinai Medical Center, Los Angeles
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Probíhá náborFáze 1
- University of Southern California, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- The Angeles Clinic and Research Institute, Los Angeles
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Probíhá náborFáze 3
- UCLA Hematology-Oncology, Los Angeles
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Probíhá náborFáze 2
- Valkyrie Clinical Trials, Los Angeles
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Probíhá náborFáze 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Probíhá náborFáze 1
- University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Probíhá náborFáze 1
- Start Lacn, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Probíhá nábor
- Oncology Institute for Hope and Innovation, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1/2
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
Probíhá náborFáze 2
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Studie Malobuněčný karcinom plic v jiných městech
- Houston, TX26 studií
- Arlington, VA23 studií
- New York City, NY22 studií
- Boston, MA21 studií
- Nashville, TN20 studií
- Orlando, FL15 studií
- Dallas, TX13 studií
- Cleveland, OH13 studií
- Chicago, IL13 studií
- St. Louis, MO13 studií
- Detroit, MI12 studií
- Washington, DC12 studií
Další studie v Los Angeles
- Nemalobuněčný plicní karcinom87 studií
- Rakovina (všechny typy)74 studií
- Rakovina prsu73 studií
- Rakovina prostaty61 studií
- Kolorektální karcinom59 studií
- Metastatický karcinom57 studií
- Rakovina vaječníků50 studií
- Rakovina plic45 studií
- Squamózní buněčný karcinom hlavy a krku42 studií
- Rakovina slinivky břišní35 studií
- Rakovina endometria34 studií
- Melanom34 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.